Scarica l'app Stockscreener
3.04
4.10%
-0.13
Dopo l'orario di chiusura:
3.25
0.21
+6.91%
Precedente Chiudi:
$3.17
Aprire:
$3.18
Volume 24 ore:
272.56K
Relative Volume:
0.70
Capitalizzazione di mercato:
$60.22M
Reddito:
-
Utile/perdita netta:
$-30.15M
Rapporto P/E:
-0.76
EPS:
-4
Flusso di cassa netto:
$-21.66M
1 W Prestazione:
-14.61%
1M Prestazione:
+2.01%
6M Prestazione:
+57.51%
1 anno Prestazione:
+147.15%
Intervallo 1D:
$3.04
$3.18
Intervallo di 1 settimana:
$2.95
$3.59
Portata 52W:
$1.12
$6.01
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Nome
Nrx Pharmaceuticals Inc
Settore
Industria
Telefono
484-254-6134
Indirizzo
1201 ORANGE STREET, WILMINGTON
Confronta NRXP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
3.04 | 72.50M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-08 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-02 | Iniziato | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Borsa (NRXP) Ultime notizie
Why NRx Pharmaceuticals Inc. Equity Warrant stock is seen as undervaluedQuarterly Market Summary & Risk Controlled Daily Trade Plans - newser.com
Live market analysis of NRx Pharmaceuticals Inc. Equity Warrant2025 Valuation Update & AI Powered Market Trend Analysis - newser.com
H.C. Wainwright reiterates Buy rating on NRx Pharmaceuticals stock at $40 - Investing.com
Will NRx Pharmaceuticals Inc. Equity Warrant stock recover faster than market2025 Pullback Review & Fast Entry High Yield Stock Tips - newser.com
Pattern recognition hints at NRx Pharmaceuticals Inc. upsideJuly 2025 Intraday Action & Community Consensus Trade Alerts - newser.com
Will NRx Pharmaceuticals Inc. Equity Warrant outperform the marketWeekly Investment Summary & Consistent Income Trade Ideas - newser.com
Using data models to predict NRx Pharmaceuticals Inc. stock movementQuarterly Portfolio Report & Growth Focused Entry Reports - newser.com
What earnings revisions data tells us about NRx Pharmaceuticals Inc. Equity WarrantRate Cut & Low Risk Investment Opportunities - newser.com
Analyzing drawdowns of NRx Pharmaceuticals Inc. Equity Warrant with statistical toolsEarnings Beat & Weekly High Conviction Trade Ideas - newser.com
Why analysts upgrade NRx Pharmaceuticals Inc. Equity Warrant stockGap Up & Free Fast Entry Momentum Trade Alerts - newser.com
Is NRx Pharmaceuticals Inc. Equity Warrant forming a bottoming base2025 Macro Impact & Low Risk Entry Point Tips - newser.com
Visual trend scoring systems applied to NRx Pharmaceuticals Inc.Trade Exit Summary & AI Powered Buy/Sell Recommendations - newser.com
Will NRx Pharmaceuticals Inc. Equity Warrant stock go up soonWeekly Market Report & Risk Controlled Daily Trade Plans - newser.com
New to The Street's Prestigious Client NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine - Florida Today
Technical signs of recovery in NRx Pharmaceuticals Inc.2025 Major Catalysts & Smart Money Movement Alerts - newser.com
Will a bounce in NRx Pharmaceuticals Inc. Equity Warrant offer an exitWeekly Market Report & Safe Entry Point Alerts - newser.com
What does recent volatility data suggest for NRx Pharmaceuticals Inc. Equity WarrantGap Down & Weekly Return Optimization Plans - newser.com
New to The Street Show #682 Premieres on Bloomberg Tonight Featuring Industry Leaders: DataVault, PetVivo, Health In Tech, FLOKI, and NRx Pharma Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustai - Corpus Christi Caller-Times
Will NRx Pharmaceuticals Inc. stock gain from government policiesJuly 2025 PreEarnings & Growth Focused Entry Point Reports - newser.com
New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group - Columbia Daily Tribune
Combining machine learning predictions for NRx Pharmaceuticals Inc.2025 Analyst Calls & Technical Confirmation Trade Alerts - newser.com
Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter - MSN
NRx Pharmaceuticals (NASDAQ: NRXP) Strengthens Pipeline with Dual Pathways for Ketamine-Based Therapies - The Globe and Mail
NRx Pharmaceuticals Inc. stock trend forecastJuly 2025 Volume & Smart Allocation Stock Reports - newser.com
Why NRx Pharmaceuticals Inc. Equity Warrant stock could outperform in 20252025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com
Earnings visualization tools for NRx Pharmaceuticals Inc. Equity WarrantJuly 2025 Sentiment & Daily Volume Surge Trade Alerts - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for NRx Pharmaceuticals (NASDAQ:NRXP) - MarketBeat
Nrx Pharmaceuticals Inc Azioni (NRXP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):